Study Details
A study to compare safety and efficacy of Prograf + Myfortic and Advagraf + Myfortic in liver transplantation patients
Clinicaltrials.gov ID
Astellas Study ID
ADVLTx-0901-TW
EudraCT ID
N/A
Condition
Liver Transplants
Phase
Phase 4
Age
18 Years - 70 Years
Sex
Female & Male
Product
N/A
Type
Interventional
Trial Dates
Apr 2009 - Dec 2010
Masking
None (Open Label)
Enrollment number
44
A Randomized, Open-Label, Comparative, Multi-Center Study to Assess the Safety and Efficacy of Prograf® (tacrolimus)/ Myfortic® and Advagraf® (extended release tacrolimus) / Myfortic® in de novo Liver Transplant Recipients
Study summary
Study documents
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to compare safety and efficacy of Prograf + Myfortic and Advagraf + Myfortic in liver transplantation patients? Contact us by filling our your information to the right and we’ll respond to you.